全球消融技術市場：市場規模和佔有率分析（依產品、應用和最終用戶）、工業需求預測（截至 2030 年）

全球消融技術市場預計到2023年將實現收入53.132億美元，2024年至2030年複合年增長率為9.0%。隨著這一成長，市場規模預計到 2030 年將達到 96.729 億美元。

這一發展是由心臟病、癌症、眼科、婦科和泌尿科等慢性疾病患者數量的快速增加所推動的。因此，對有效手術治療的需求不斷增加，對消融裝置的需求也增加。

射頻消融儀主導市場

2023 年，射頻消融器細分市場佔最大佔有率，達到 25%。此外，預測期內複合年增長率預計為 9.2%。

隨著 RFA 越來越多地用於治療多種疾病，包括良性和腫瘤性腫瘤、慢性頸部和背部疼痛以及腿部慢性靜脈缺陷，這個類別正在不斷增長。

消融技術最常用於心血管治療

就2023年的申請量而言，心血管類別佔最大佔有率。

消融技術廣泛用於治療心房顫動，並有助於破壞導致心律不整的不規則電訊號。

北美市場佔最大佔有率

2023年，北美地區是消融技術產業最大的市場。這是由於這項技術的發展以及對其許多治療應用的瞭解不斷增加。

預測期內，亞太地區將以 9.5% 的複合年增長率成長最快。這是由於有關微創方法的知識迅速增加、醫療保健系統的發展和經濟成長。

本報告分析了全球消融技術市場，並提供了市場的基本結構和最新情況、主要促進和抑制因素以及全球、依地區和主要國家的市場規模前景（價值基礎，2017-2030年） ），依產品、應用和最終用戶劃分的詳細趨勢、市場競爭的現狀以及主要公司的概況。

目錄

第一章 調查範圍

第二章研究方法

第3章執行摘要

第四章 市場指標

第五章 產業展望

• 市場動態
  • 趨勢
  • 促進因素
  • 抑制因素/課題
  • 促進/抑制因素影響分析
• 新型冠狀病毒感染（COVID-19）的影響
• 波特五力分析

第六章 世界市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依最終用戶分類（2017-2030）
• 市場收入：依地區（2017-2030）

第七章 北美市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依最終用戶分類（2017-2030）
• 市場收入：依國家分類（2017-2030）

第八章歐洲市場

第九章亞太市場

第十章 拉丁美洲市場

第十一章 中東和非洲（MEA）市場

第十二章 美國市場

• 概述
• 市場收入：依產品分類（2017-2030）
• 市場收入：依應用分類（2017-2030）
• 市場收入：依最終用戶分類（2017-2030）

第十三章 加拿大市場

第十四章 德國市場

第十五章 法國市場

第十六章 英國市場

第十七章 義大利市場

第十八章 西班牙市場

第十九章 日本市場

第20章 中國市場

第21章 印度市場

第22章澳洲市場

第23章 韓國市場

第24章 巴西市場

第25章 墨西哥市場

第26章 沙烏地阿拉伯市場

第27章南非市場

第28章 阿拉伯聯合大公國（UAE）市場

第29章競爭格局

• 市場參與者及其提供的產品/服務的列表
• 主要企業競爭基準
• 主要公司的產品基準
• 近期策略發展狀況

第三十章 公司簡介

• Medtronic plc.
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• Boston Scientific Corporation
• Olympus Corporation
• Stryker Corporation
• Smith & Nephew plc
• Varian Medical Systems Inc.
• CONMED Corporation
• AngioDynamics Inc.

第31章附錄

The ablation technology market worldwide achieved revenue of USD 5,313.2 million in

2023, and it is anticipated to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2030. This growth is expected to lead to a market size of USD 9,672.9 million by the year 2030.

The development can be credited to the surge in the count of cases of chronic diseases, like heart diseases, cancer, and ophthalmologic, gynecological, and urological diseases. As a result, there is an increased need for efficient surgical treatments, leading to higher demand for ablation devices.

Market Trends/Drivers

The increasing awareness regarding ablation procedures, growing healthcare spending, growing count of cancer cases, less cost of this procedure, and technical enhancements in related devices are the key reasons boosting the industry.

The growing count of hospitals and ambulatory operation centers is projected to fuel the development of the industry.

The growth in the ageing populace and surge in the need for minimally invasive procedures, credited to their benefits over the conventional, open procedures, will boost the product need.

Furthermore, minimally invasive methods provide precise results and are inexpensive for both care patients and providers. Moreover, the range of these procedures obtainable for different parts of the body, like brain surgeries, adrenalectomies, hiatal hernia repairs, colectomies, and nephrectomies, has made them enormously popular.

The Market Is Dominated by Radiofrequency Ablators

The radiofrequency ablators segment held the largest share, 25%, in 2023.

It is projected to experience a CAGR of 9.2% during the projection period.

This category is growing because of the growing utilization of RFA for several treatments like benign and oncogenic tumors, chronic neck and back pain, chronic venous deficiency in the legs, and more.

RFA is also used for treating atrial fibrillation, an irregular heartbeat condition.

FDA approvals for advanced radiofrequency ablators are expected to further boost the market.

Example: RF Medical Co. Ltd. received FDA clearance in December 2022 for its MYGEN M-3004 generator and MYOBLATE RFA system for use in the U.S.

Laser ablation also grips a substantial share in the industry, because of the research being done on this technology. In their January 2023 study, researchers showed that the co-administration of compression therapy with endovenous laser ablation positively impacted the rate of healing of venous ulcers and reduced the likelihood of recurrence.

Ablation Technology Founds Its Highest Usage in Cardiovascular Treatments

The cardiovascular category held the largest share in 2023 in terms of application.

Ablation technology is extensively used in treating atrial fibrillation, aiding in disrupting the irregular electrical signals responsible for irregular heartbeats.

Each cell in the myocardium generates its own signal for heartbeat, and when synchronization fails among cells, arrhythmia (irregular heartbeat) can result.

Ablation procedures are utilized to block the aberrant electric signals causing arrhythmias, restoring normal heart rhythm.

North America Held the Largest Share in the Market

In 2023, the North American region was the largest customer in the ablation technology industry, because of the growth in the technology and increasing knowledge about its applications in many treatments.

The surge in the count of patients who are suffering from chronic diseases mainly cancer is contributing to the development of the industry. Already, cancer is one of the top 10 foremost causes of demise in the nation. Its death rate is projected to surge to approximately 3 million by the end of 2040. also, approximately 37.3 million individuals in the nation were found to have diabetes, and about 96 million grownups were found to have pre-diabetes.

During the projection period, the Asia-Pacific region will be the fastest-rising ablation tech industry, with a CAGR of 9.5%. This can be credited to the surging knowledge regarding minimally invasive methods, growing healthcare systems, and rising economies.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by end user
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by End User (2017-2030)
• 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by End User (2017-2030)
• 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by End User (2017-2030)
• 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by End User (2017-2030)
• 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by End User (2017-2030)
• 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by End User (2017-2030)
• 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Medtronic plc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Johnson & Johnson Services Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Abbott Laboratories
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Boston Scientific Corporation
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Olympus Corporation
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Stryker Corporation
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Smith & Nephew plc
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Varian Medical Systems Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. CONMED Corporation
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. AngioDynamics Inc.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports